Zurich, October 15, 2019: Mylan entering Swiss generics market – Shepard Fox helps global number 1 in generic pharmaceuticals in raising media and brand awareness in Switzerland
Although Mylan has been present on the Swiss market for a long time via acquired brands, the global leader in generic pharmaceuticals only entered the Swiss generics market under its own brand in 2019. The Swiss generics market is considered to be particularly demanding: two players control more than 70% of the relatively small market that requires every new product to undergo extensive tests to meet Swiss approval standards. In addition generics only have a 35% market share compared to 80% in Germany. – In a series of interviews (see links for samples) with Swiss lead media, Mylan’s Swiss CEO explains the strategy for the Swiss market and which objectives the company is pursuing in the coming years. Shepard Fox supports Mylan in arranging and preparing the interviews which are part of a jointly developed media relations strategy and action plan aimed at raising awareness for Mylan among health care professionals and patients.